Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial Cancers
Yanli Liu, Bingqian Guo, Estrella Aguilera-Jimenez, et al.
Cancer Research (2020) Vol. 80, Iss. 24, pp. 5464-5477
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes
Tasnim H. Beacon, Geneviève P. Delcuve, Camila López, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 158
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis
Seongryong Kim, Galam Leem, Junjeong Choi, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 21
The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
Juan Luo, Hailin Zou, Yibo Guo, et al.
British Journal of Cancer (2023)
Open Access | Times Cited: 41
KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency
Samah W. Awwad, Colm Doyle, Josie Coulthard, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Regulatory SNPs: Altered Transcription Factor Binding Sites Implicated in Complex Traits and Diseases
A. O. Degtyareva, E. V. Antontseva, Т. И. Меркулова
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6454-6454
Open Access | Times Cited: 55
KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer
Yong Wu, Siyu Chen, Yang Shao, et al.
Advanced Science (2023) Vol. 10, Iss. 31
Open Access | Times Cited: 21
KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8+ T-cell-dependent antitumor immunity
Qi Wu, Zhou Liu, Zhijie Gao, et al.
Theranostics (2023) Vol. 13, Iss. 4, pp. 1381-1400
Open Access | Times Cited: 20
Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer
Hailin Zou, Juan Luo, Yibo Guo, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 17
Machine learning identifies activation of RUNX/AP-1 as drivers of mesenchymal and fibrotic regulatory programs in gastric cancer
Milad Razavi-Mohseni, Weitai Huang, Yu Amanda Guo, et al.
Genome Research (2024) Vol. 34, Iss. 5, pp. 680-695
Open Access | Times Cited: 8
3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression
Katelyn L. Mortenson, Courtney Dawes, Emily R. Wilson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer
Yanli Liu, Zhong Wu, Jin Zhou, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
CCL7 and TGF-β secreted by MSCs play opposite roles in regulating CRC metastasis in a KLF5/CXCL5-dependent manner
Zhuoqing Xu, Han Gao, Yuchen Zhang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 6, pp. 2327-2341
Open Access | Times Cited: 25
Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin
Jan Attig, Judith Pape, Laura Doglio, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 14
Open Access | Times Cited: 14
Klf5 defines alveolar epithelial type 1 cell lineage commitment during lung development and regeneration
Derek C. Liberti, William A. Liberti, Madison M. Kremp, et al.
Developmental Cell (2022) Vol. 57, Iss. 14, pp. 1742-1757.e5
Open Access | Times Cited: 22
Spatial promoter–enhancer hubs in cancer: organization, regulation, and function
Jingru Zhao, Robert B. Faryabi
Trends in cancer (2023) Vol. 9, Iss. 12, pp. 1069-1084
Open Access | Times Cited: 13
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes
Shilpa Bisht, Yiqing Mao, Hariharan Easwaran
Current Opinion in Oncology (2024) Vol. 36, Iss. 2, pp. 82-92
Closed Access | Times Cited: 4
Reorganization of 3D genome architecture provides insights into pathogenesis of early fatty liver disease in laying hens
Yanli Liu, Zhuqing Zheng, Chaohui Wang, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Systemic genome-epigenome analysis captures a lineage-specific super-enhancer for MYB in gastrointestinal adenocarcinoma
Fuyuan Li, Shangzi Wang, Lian Chen, et al.
Molecular Systems Biology (2025)
Open Access
Multilevel view on chromatin architecture alterations in cancer
Maria Gridina, Veniamin Fishman
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 15
The 3D genome and its impacts on human health and disease
Siqi Wang, Zhengyu Luo, Weiguang Liu, et al.
Life Medicine (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 8
KLF5 regulates actin remodeling to enhance the metastasis of nasopharyngeal carcinoma
Zhenyu Yang, Yanfu Peng, Yaqin Wang, et al.
Oncogene (2024) Vol. 43, Iss. 23, pp. 1779-1795
Open Access | Times Cited: 2
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
Gongwei Wu, Noriaki Yoshida, Jihe Liu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 714
Open Access | Times Cited: 6
The transcriptional activator Klf5 recruits p300-mediated H3K27ac for maintaining trophoblast stem cell pluripotency
Chengli Dou, Linhui Wu, Jingjing Zhang, et al.
Journal of Molecular Cell Biology (2023) Vol. 15, Iss. 7
Open Access | Times Cited: 5
Pluripotency Stemness and Cancer: More Questions than Answers
Jiřı́ Hatina, Michaela Kripnerová, Zbyněk Houdek, et al.
Advances in experimental medicine and biology (2021), pp. 77-100
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top